Literature DB >> 6237739

Maturational impairment of thymic lymphocytes in streptozotocin-induced diabetes in rats.

T Tabata, Y Okuno, S Fujii, S Kimura, Y Kinoshita.   

Abstract

Streptozotocin (STZ)-induced diabetes in rats was associated with marked decreases in thymus weight and the number of thymic lymphocytes. Histologically, the cortical lymphocytes which were present near the cortico-medullary junction in the thymus seemed to be reduced selectively in the STZ-induced diabetes. Rosette-forming cells, which bind to guinea pig erythrocytes in the presence of fetal calf serum, were also significantly decreased. Insulin treatment allayed these intrathymic changes. Preincubation of thymic lymphocytes from diabetic rats with thymosin fraction 5 significantly enhanced the percentage of rosette-forming cells to near the control level. These results suggest that a maturational impairment of thymus cortical lymphocytes may be caused in STZ-induced diabetes with hypoinsulinemia and it may be intimately related to reductions in thymus weight and the number of thymic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237739     DOI: 10.1016/0008-8749(84)90216-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes.

Authors:  Yu Zhen; Lina Sun; He Liu; Kaizhong Duan; Chun Zeng; Lianjun Zhang; Di Jin; Jianxia Peng; Wenjun Ding; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2011-10-10       Impact factor: 11.530

2.  The binding of FITC-insulin to ANAE-positive cells in rat thymus.

Authors:  J F Hofert; T A Mahowald; N A Mahowald; M L Heidrick
Journal:  Experientia       Date:  1988-01-15

3.  Arachidonic acid accumulates in the stromal macrophages during thymus involution in diabetes.

Authors:  Alexandra T Gruia; Lucian Barbu-Tudoran; Ani A Mic; Valentin L Ordodi; Virgil Paunescu; Felix A Mic
Journal:  Histochem Cell Biol       Date:  2011-05-29       Impact factor: 4.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.